Physician

Abdallah M. Rizk, MD

According to 2025 Medicare claims, Abdallah Rizk, MD (NPI: 1689641664) practices internal medicine in the Warren-Troy-Farmington Hills, MI market, with the plurality of this provider's patient population coming from Oakland, MI. This provider's primary affiliated billing organization is MCLAREN MEDICAL GROUP (NPI: 1346396066; TIN: 38-2988086) and primary practice location at 48346-2092. Rizk is affiliated with the McLaren High Performance Network, LLC (ACO ID: A3317), participating under the MSSP model.

Rizk's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 162 traditional Medicare patients, billed 1,616 HCPCS/CPT codes, and received $73,593 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 7,058 prescription claims across 415 beneficiaries totaling $732,108 in drug costs, led by Jardiance (Empagliflozin). DME data shows 65 claims. Open Payments data shows 9 records totaling $164. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $528,310 to $732,108. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $13,164 and ending at $4,826.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	236	989	$57,295
2016	223	965	$56,488
2017	229	1,029	$68,584
2018	182	1,242	$63,273
2019	191	1,418	$69,333
2020	160	1,140	$51,457
2021	160	1,503	$60,686
2022	159	1,239	$68,654
2023	164	1,319	$81,703
2024	162	1,616	$73,593

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	379	6,286	$528,310
2016	346	6,335	$526,858
2017	356	6,395	$497,139
2018	333	6,009	$418,205
2019	343	5,724	$437,237
2020	342	5,823	$502,731
2021	363	5,817	$505,331
2022	385	6,374	$614,957
2023	394	6,619	$616,286
2024	415	7,058	$732,108

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	164	615	$12,745
2016	113	339	$6,066
2017	104	346	$4,522
2018	52	199	$3,409
2019	13	78	$628
2020	13	65	$618
2021	N/R	38	$435
2022	N/R	65	$664
2023	N/R	33	$469
2024	N/R	65	$1,388

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	93	93	$139
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	150	436	$91
G0008	Administration of influenza virus vaccine	43	43	$32
36415	Insertion of needle into vein for collection of blood sample	123	218	$8
81003	Automated urinalysis test	104	132	$2

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Jardiance	Empagliflozin	145	7,000	$130,937
Januvia	Sitagliptin Phosphate	83	6,191	$108,990
Eliquis	Apixaban	69	3,641	$68,059
Ozempic	Semaglutide	50	1,750	$57,231
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	37	1,590	$32,779

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	12	$836
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	N/R	14	$300
E0431	Portable gaseous oxygen system, rental; includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubing	Y	N/R	12	$181
E0570	Nebulizer, with compressor	Y	N/R	11	$49
A4259	Lancets, per box of 100	N	N/R	16	$21

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	9	$164	Lilly USA, LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Abdallah M. Rizk, MD?

Tedicare shows public-source Medicare data for Abdallah M. Rizk, MD (NPI 1689641664), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Abdallah M. Rizk, MD have ACO affiliation data?

Abdallah M. Rizk, MD is shown with ACO affiliation data for McLaren High Performance Network, LLC (MSSP, ACO ID A3317).

What billing organization is linked to Abdallah M. Rizk, MD?

Abdallah M. Rizk, MD is linked to MCLAREN MEDICAL GROUP (billing NPI 1346396066) in the available physician profile data.

Does Abdallah M. Rizk, MD have Open Payments data?

Abdallah M. Rizk, MD has 9 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.